Most critics take Dopesick seriously as an angry, clear account of how Purdue Pharma pushed OxyContin and what it did to the people who took it. The praise gathers around the human stories rather than the corporate ones, and around Michael Keaton’s performance as a doctor drawn into addiction, which several reviews single out. Even those who like it least concede it is passionate and often affecting, and nobody doubts the case it makes against corporate greed and the regulators who let it happen.
The reservations are almost all about structure. Review after review says the series tries to carry too many threads across too many years, and that the time-hopping blunts the momentum the individual stories build. The spread is wide: Paste rates it highly for its accuracy and ensemble, while IndieWire thinks a dense, dour eight-part series is the wrong shape for the material, and The Hollywood Reporter finds some performances flat or melodramatic.
